| Health / Medical Topics |
Idelalisib
Pronunciation
An orally bioavailable, small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. Idelalisib inhibits the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3), preventing the activation of the PI3K signaling pathway and inhibiting tumor cell proliferation, motility, and survival. Unlike other isoforms of PI3K, PI3K-delta is expressed primarily in hematopoietic lineages. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the…
The date and time span specifying the best time for an activity or event to begin and end.
Conforming to an ultimate standard of perfection or excellence.
Human IDE wild-type allele is located within 10q23-q25 and is approximately 122 kb in length. This allele, which encodes insulin-degrading enzyme protein,…
This gene is involved in the catabolism of insulin and other bioactive peptides.
A sustained-release drug delivery embolization system containing small polymeric beads impregnated with the anthracycline antibiotic idarubicin with potential antineoplastic activity. The beads…
